Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 228,399,324 papers from all fields of science
Search
Sign In
Create Free Account
tiotropium
Known as:
Tiotropium [Chemical/Ingredient]
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
11 relations
28 ACTUAT tiotropium 0.0025 MG/ACTUAT Metered Dose Inhaler [Spiriva]
60 ACTUAT olodaterol 0.0025 MG/ACTUAT / tiotropium 0.0025 MG/ACTUAT Metered Dose Inhaler
60 ACTUAT tiotropium 0.00125 MG/ACTUAT Metered Dose Inhaler
60 ACTUAT tiotropium 0.0025 MG/ACTUAT Metered Dose Inhaler [Spiriva]
Expand
Narrower (2)
Spiriva
tiotropium bromide
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Rates of escalation to triple COPD therapy among incident users of LAMA and LAMA/LABA.
B. Hahn
,
M. Hull
,
C. Blauer-Peterson
,
A. Buikema
,
R. Ray
,
R. Stanford
Respiratory Medicine
2018
Corpus ID: 46917958
2017
2017
The effect of indacaterol/glycopyrronium versus tiotropium or salmeterol/fluticasone on the prevention of clinically important deterioration in COPD
A. Anzueto
,
C. Vogelmeier
,
+6 authors
R. Fogel
International Journal of COPD
2017
Corpus ID: 4001398
Background Endpoints that evaluate deterioration rather than improvement of disease may have clinical utility in COPD. In this…
Expand
Review
2012
Review
2012
Efficacy of Tiotropium in COPD Patients with FEV1 ≥ 60% Participating in the UPLIFT® Trial
D. Tashkin
,
B. Celli
,
M. Decramer
,
T. Lystig
,
Dacheng Liu
,
S. Kesten
COPD
2012
Corpus ID: 24018011
Abstract GOLD stage II COPD encompasses patients with FEV1 50–80% predicted. A published trials review suggested that benefits of…
Expand
2011
2011
Choice of bronchodilator therapy for patients with COPD.
J. Wedzicha
New England Journal of Medicine
2011
Corpus ID: 40714676
Chronic obstructive pulmonary disease (COPD) is a progressive airway inflammatory condition that is associated with accelerated…
Expand
Review
2009
Review
2009
Combination of Formoterol and Tiotropium in the Treatment of COPD: Effects on Lung Function
M. Cazzola
,
D. Tashkin
COPD
2009
Corpus ID: 36792580
Bronchodilators are central in symptomatic management of all stages of COPD. For patients whose COPD is not sufficiently…
Expand
2009
2009
Tiotropium reduction of lung inflammation in a model of chronic gastro-oesophageal reflux
Yong-yao Cui
,
P. Devillier
,
+7 authors
H. Chen
European Respiratory Journal
2009
Corpus ID: 1302706
Gastro-oesophageal reflux is frequent in chronic airway diseases and is considered a trigger for symptoms. In animal models…
Expand
Highly Cited
2007
Highly Cited
2007
MAPK pathway mediates muscarinic receptor-induced human lung fibroblast proliferation.
S. Matthiesen
,
Amit Bahulayan
,
O. Holz
,
K. Racké
Life Science
2007
Corpus ID: 34651318
Highly Cited
2006
Highly Cited
2006
Muscarinic receptors mediate stimulation of human lung fibroblast proliferation.
S. Matthiesen
,
Amit Bahulayan
,
+5 authors
K. Racké
American Journal of Respiratory Cell and…
2006
Corpus ID: 12738153
Airway remodeling is a structural alteration associated with chronic inflammatory and obstructive airway diseases, wherein…
Expand
2006
2006
Onset and Duration of Action of Formoterol and Tiotropium in Patients with Moderate to Severe COPD
K. Richter
,
S. Stenglein
,
+5 authors
H. Magnussen
Respiration
2006
Corpus ID: 37770138
Background: Chronic obstructive pulmonary disease (COPD) management guidelines recommend regular treatment with one or more long…
Expand
2004
2004
Patient-centred outcomes in primary care management of COPD - what do recent clinical trial data tell us?
J. Haughney
,
K. Gruffydd-Jones
Primary Care Respiratory Journal
2004
Corpus ID: 21188890
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE